Page 147 - 2019秋季手冊內頁-ebook測試

Minor MHC-mismatch chronic skin GVHD model has DIO recipients instead showing lethal aGVHD
100
50
0
Control with B M + splenocytes Control with BM
DIO with BM
DIO with BM + splenocytes
0 102030405060 Days post HSCT
Khuat et al., submitted
• Control recipients survive and much later develop later cGVHD only in skin.
• DIO recipients succumb to rapid lethal gut aGVHD.
Obesity (>30 BMI) results in poorer outcome in adult patients post-alloHSCT
Khuat et al., submitted
148
Percent survival